{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:26:12Z","timestamp":1787073972652,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004853","name":"The Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154288","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:50:50Z","timestamp":1784044250000},"page":"154288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ion channel TRPML2 (MCOLN2) promotes ovarian cancer metastasis and chemoresistance"],"prefix":"10.1016","volume":"831","author":[{"given":"Shizhang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-8186","authenticated-orcid":false,"given":"Xiaoqiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154288_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","article-title":"Tumor evolution and chemoresistance in ovarian cancer","volume":"2","author":"Kim","year":"2018","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bbrc.2026.154288_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int .J. Womens Health"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154288_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154288_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fonc.2020.00659","article-title":"Emerging role of mucolipins TRPML channels in cancer","volume":"10","author":"Santoni","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154288_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/biom11010065","article-title":"Endolysosomal TRPMLs in cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154288_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tibs.2018.10.006","article-title":"Lysosomal ion channels as decoders of cellular signals","volume":"44","author":"Li","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2026.154288_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fimmu.2020.00739","article-title":"Involvement of the TRPML mucolipin channels in viral infections and anti-viral innate immune responses","volume":"11","author":"Santoni","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154288_bib8","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1080\/15548627.2021.1917132","article-title":"MCOLN1\/TRPML1 finely controls oncogenic autophagy in cancer by mediating zinc influx","volume":"17","author":"Qi","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154288_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105581","article-title":"Endolysosomal TRPML1 channel regulates cancer cell migration by altering intracellular trafficking of E-cadherin and \u03b21-integrin","volume":"300","author":"Frey","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154288_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ceca.2019.02.010","article-title":"The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways","volume":"79","author":"Xu","year":"2019","journal-title":"Cell Calcium"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154288_bib11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.celrep.2019.07.086","article-title":"TRPML1 promotes protein homeostasis in Melanoma cells by negatively regulating MAPK and mTORC1 signaling","volume":"28","author":"Kasitinon","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154288_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846685","article-title":"HRAS-driven cancer cells are vulnerable to TRPML1 inhibition","volume":"20","author":"Jung","year":"2019","journal-title":"EMBO Rep."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154288_bib13","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.4049\/jimmunol.1500163","article-title":"Novel role of TRPML2 in the regulation of the innate immune response","volume":"195","author":"Sun","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154288_bib14","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1038\/s41467-025-60710-8","article-title":"TRPML2 in distinct states reveals the activation and modulation principles of the TRPML family","volume":"16","author":"Schmiege","year":"2025","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.bbrc.2026.154288_bib15","doi-asserted-by":"crossref","first-page":"43654","DOI":"10.18632\/oncotarget.9661","article-title":"Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression","volume":"7","author":"Morelli","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.bbrc.2026.154288_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315356","article-title":"TRPML2 Mucolipin channels drive the response of glioma stem cells to temozolomide and affect the overall survival in glioblastoma patients","volume":"23","author":"Morelli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154288_bib17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41416-021-01537-0","article-title":"Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1\u03b2\/NF-\u03baB pathway","volume":"125","author":"Yu","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154288_bib18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.gendis.2020.11.017","article-title":"Revisiting chemoresistance in ovarian cancer: mechanism, biomarkers, and precision medicine","volume":"9","author":"Guo","year":"2020","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154288_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/0109298673276871231205043417","article-title":"Therapeutic chemoresistance in ovarian cancer: emerging hallmarks, signaling mechanisms and alternative pathways","volume":"32","author":"Zaib","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154288_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-3-030-12457-1_20","article-title":"Calcium signaling and the regulation of chemosensitivity in cancer cells: role of the transient receptor potential channels","volume":"1131","author":"Santoni","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"40","key":"10.1016\/j.bbrc.2026.154288_bib21","doi-asserted-by":"crossref","first-page":"16282","DOI":"10.1073\/pnas.1202989109","article-title":"Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells","volume":"109","author":"Ma","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154288_bib22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11010-024-05054-5","article-title":"Lysosomal cation channel TRPML1 suppression sensitizes acute myeloid leukemia cells to chemotherapeutics by inhibiting autophagy","volume":"480","author":"Dai","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.154288_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2022.08.051","article-title":"TRPML3 enhances drug resistance in non-small cell lung cancer cells by promoting Ca2+-mediated lysosomal trafficking","volume":"627","author":"Kim","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.bbrc.2026.154288_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315356","article-title":"TRPML2 Mucolipin channels drive the response of glioma stem cells to temozolomide and affect the overall survival in glioblastoma patients","volume":"23","author":"Morelli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154288_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/0109298673276871231205043417","article-title":"Therapeutic chemoresistance in ovarian cancer: emerging hallmarks, signaling mechanisms and alternative pathways","volume":"32","author":"Zaib","year":"2025","journal-title":"Curr. Med. Chem."},{"issue":"28","key":"10.1016\/j.bbrc.2026.154288_bib26","doi-asserted-by":"crossref","first-page":"43654","DOI":"10.18632\/oncotarget.9661","article-title":"Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression","volume":"7","author":"Morelli","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154288_bib27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.str.2019.04.016","article-title":"Structure of the Human TRPML2 ion channel Extracytosolic\/Lumenal domain","volume":"27","author":"Viet","year":"2019","journal-title":"Structure"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:18Z","timestamp":1787070978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S0006291X26010521"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154288","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ion channel TRPML2 (MCOLN2) promotes ovarian cancer metastasis and chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154288"}}